BUILDERS FIRSTSOURCE INC (BLDR) Fundamental Analysis & Valuation

NYSE:BLDR • US12008R1077

93.12 USD
-2.39 (-2.5%)
At close: Mar 6, 2026
92.99 USD
-0.13 (-0.14%)
After Hours: 3/6/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BLDR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Taking everything into account, BLDR scores 4 out of 10 in our fundamental rating. BLDR was compared to 42 industry peers in the Building Products industry. BLDR has only an average score on both its financial health and profitability. BLDR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. BLDR Profitability Analysis

1.1 Basic Checks

  • In the past year BLDR was profitable.
  • In the past year BLDR had a positive cash flow from operations.
  • BLDR had positive earnings in each of the past 5 years.
  • Each year in the past 5 years BLDR had a positive operating cash flow.
BLDR Yearly Net Income VS EBIT VS OCF VS FCFBLDR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • BLDR has a Return On Assets (3.87%) which is in line with its industry peers.
  • With a Return On Equity value of 10.00%, BLDR perfoms like the industry average, outperforming 54.76% of the companies in the same industry.
  • BLDR's Return On Invested Capital of 6.62% is on the low side compared to the rest of the industry. BLDR is outperformed by 61.90% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLDR is above the industry average of 11.88%.
  • The last Return On Invested Capital (6.62%) for BLDR is well below the 3 year average (13.95%), which needs to be investigated, but indicates that BLDR had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.87%
ROE 10%
ROIC 6.62%
ROA(3y)9.58%
ROA(5y)14.16%
ROE(3y)22.55%
ROE(5y)31.79%
ROIC(3y)13.95%
ROIC(5y)19.93%
BLDR Yearly ROA, ROE, ROICBLDR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.86%, BLDR is in line with its industry, outperforming 40.48% of the companies in the same industry.
  • In the last couple of years the Profit Margin of BLDR has declined.
  • BLDR has a Operating Margin of 5.18%. This is in the lower half of the industry: BLDR underperforms 76.19% of its industry peers.
  • BLDR's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 30.39%, BLDR is in line with its industry, outperforming 52.38% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BLDR has grown nicely.
Industry RankSector Rank
OM 5.18%
PM (TTM) 2.86%
GM 30.39%
OM growth 3Y-32.17%
OM growth 5Y-4.02%
PM growth 3Y-38.13%
PM growth 5Y-4.83%
GM growth 3Y-3.75%
GM growth 5Y3.19%
BLDR Yearly Profit, Operating, Gross MarginsBLDR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. BLDR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BLDR is still creating some value.
  • Compared to 1 year ago, BLDR has less shares outstanding
  • Compared to 5 years ago, BLDR has less shares outstanding
  • The debt/assets ratio for BLDR is higher compared to a year ago.
BLDR Yearly Shares OutstandingBLDR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BLDR Yearly Total Debt VS Total AssetsBLDR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • BLDR has an Altman-Z score of 2.67. This is not the best score and indicates that BLDR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.67, BLDR perfoms like the industry average, outperforming 40.48% of the companies in the same industry.
  • BLDR has a debt to FCF ratio of 5.21. This is a neutral value as BLDR would need 5.21 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 5.21, BLDR perfoms like the industry average, outperforming 45.24% of the companies in the same industry.
  • A Debt/Equity ratio of 1.02 is on the high side and indicates that BLDR has dependencies on debt financing.
  • BLDR's Debt to Equity ratio of 1.02 is on the low side compared to the rest of the industry. BLDR is outperformed by 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 5.21
Altman-Z 2.67
ROIC/WACC0.72
WACC9.13%
BLDR Yearly LT Debt VS Equity VS FCFBLDR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.86 indicates that BLDR should not have too much problems paying its short term obligations.
  • BLDR's Current ratio of 1.86 is in line compared to the rest of the industry. BLDR outperforms 50.00% of its industry peers.
  • BLDR has a Quick Ratio of 1.16. This is a normal value and indicates that BLDR is financially healthy and should not expect problems in meeting its short term obligations.
  • BLDR has a Quick ratio (1.16) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.16
BLDR Yearly Current Assets VS Current LiabilitesBLDR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BLDR Growth Analysis

3.1 Past

  • BLDR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.24%.
  • The Earnings Per Share has been growing by 17.40% on average over the past years. This is quite good.
  • The Revenue has decreased by -7.38% in the past year.
  • The Revenue has been growing by 12.16% on average over the past years. This is quite good.
EPS 1Y (TTM)-40.24%
EPS 3Y-28.14%
EPS 5Y17.4%
EPS Q2Q%-51.52%
Revenue 1Y (TTM)-7.38%
Revenue growth 3Y-12.57%
Revenue growth 5Y12.16%
Sales Q2Q%2.37%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.16% on average over the next years. This is quite good.
  • BLDR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.01% yearly.
EPS Next Y-11.26%
EPS Next 2Y7.34%
EPS Next 3Y14.16%
EPS Next 5YN/A
Revenue Next Year-0.62%
Revenue Next 2Y2.63%
Revenue Next 3Y4.01%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLDR Yearly Revenue VS EstimatesBLDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
BLDR Yearly EPS VS EstimatesBLDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. BLDR Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.52, the valuation of BLDR can be described as correct.
  • Based on the Price/Earnings ratio, BLDR is valued a bit cheaper than the industry average as 76.19% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of BLDR to the average of the S&P500 Index (26.29), we can say BLDR is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 15.23, which indicates a correct valuation of BLDR.
  • BLDR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BLDR is cheaper than 69.05% of the companies in the same industry.
  • BLDR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.57.
Industry RankSector Rank
PE 13.52
Fwd PE 15.23
BLDR Price Earnings VS Forward Price EarningsBLDR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • BLDR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BLDR is cheaper than 66.67% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BLDR is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.07
EV/EBITDA 10.76
BLDR Per share dataBLDR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • BLDR's earnings are expected to grow with 14.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.78
EPS Next 2Y7.34%
EPS Next 3Y14.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BLDR Dividend Analysis

5.1 Amount

  • BLDR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLDR Fundamentals: All Metrics, Ratios and Statistics

BUILDERS FIRSTSOURCE INC

NYSE:BLDR (3/6/2026, 8:04:00 PM)

After market: 92.99 -0.13 (-0.14%)

93.12

-2.39 (-2.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)02-17
Earnings (Next)04-29
Inst Owners96.29%
Inst Owner Change-5.29%
Ins Owners2.49%
Ins Owner Change0.08%
Market Cap10.30B
Revenue(TTM)15.19B
Net Income(TTM)435.20M
Analysts72.26
Price Target131.26 (40.96%)
Short Float %4.37%
Short Ratio2.25
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.45%
Min EPS beat(2)-11.6%
Max EPS beat(2)12.49%
EPS beat(4)3
Avg EPS beat(4)3.94%
Min EPS beat(4)-11.6%
Max EPS beat(4)12.49%
EPS beat(8)7
Avg EPS beat(8)6.47%
EPS beat(12)11
Avg EPS beat(12)20.34%
EPS beat(16)15
Avg EPS beat(16)32.8%
Revenue beat(2)1
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-4.82%
Max Revenue beat(2)0.31%
Revenue beat(4)1
Avg Revenue beat(4)-2.35%
Min Revenue beat(4)-4.82%
Max Revenue beat(4)0.31%
Revenue beat(8)1
Avg Revenue beat(8)-4.56%
Revenue beat(12)4
Avg Revenue beat(12)-2.6%
Revenue beat(16)8
Avg Revenue beat(16)1.22%
PT rev (1m)-2.06%
PT rev (3m)-4.93%
EPS NQ rev (1m)-50.46%
EPS NQ rev (3m)-54.66%
EPS NY rev (1m)-2.99%
EPS NY rev (3m)-7.88%
Revenue NQ rev (1m)-4.69%
Revenue NQ rev (3m)-6.02%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.05%
Valuation
Industry RankSector Rank
PE 13.52
Fwd PE 15.23
P/S 0.68
P/FCF 12.07
P/OCF 8.47
P/B 2.37
P/tB N/A
EV/EBITDA 10.76
EPS(TTM)6.89
EY7.4%
EPS(NY)6.11
Fwd EY6.57%
FCF(TTM)7.72
FCFY8.29%
OCF(TTM)11
OCFY11.81%
SpS137.37
BVpS39.36
TBVpS-8.76
PEG (NY)N/A
PEG (5Y)0.78
Graham Number78.11
Profitability
Industry RankSector Rank
ROA 3.87%
ROE 10%
ROCE 8.14%
ROIC 6.62%
ROICexc 6.75%
ROICexgc 15.37%
OM 5.18%
PM (TTM) 2.86%
GM 30.39%
FCFM 5.62%
ROA(3y)9.58%
ROA(5y)14.16%
ROE(3y)22.55%
ROE(5y)31.79%
ROIC(3y)13.95%
ROIC(5y)19.93%
ROICexc(3y)14.13%
ROICexc(5y)20.13%
ROICexgc(3y)32.17%
ROICexgc(5y)46.7%
ROCE(3y)17.15%
ROCE(5y)24.51%
ROICexgc growth 3Y-43.15%
ROICexgc growth 5Y-9.26%
ROICexc growth 3Y-42.43%
ROICexc growth 5Y-16.42%
OM growth 3Y-32.17%
OM growth 5Y-4.02%
PM growth 3Y-38.13%
PM growth 5Y-4.83%
GM growth 3Y-3.75%
GM growth 5Y3.19%
F-Score5
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 5.21
Debt/EBITDA 3.21
Cap/Depr 61.31%
Cap/Sales 2.39%
Interest Coverage 3.02
Cash Conversion 88.24%
Profit Quality 196.07%
Current Ratio 1.86
Quick Ratio 1.16
Altman-Z 2.67
F-Score5
WACC9.13%
ROIC/WACC0.72
Cap/Depr(3y)71.45%
Cap/Depr(5y)64.89%
Cap/Sales(3y)2.5%
Cap/Sales(5y)2.03%
Profit Quality(3y)151.11%
Profit Quality(5y)131.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-40.24%
EPS 3Y-28.14%
EPS 5Y17.4%
EPS Q2Q%-51.52%
EPS Next Y-11.26%
EPS Next 2Y7.34%
EPS Next 3Y14.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.38%
Revenue growth 3Y-12.57%
Revenue growth 5Y12.16%
Sales Q2Q%2.37%
Revenue Next Year-0.62%
Revenue Next 2Y2.63%
Revenue Next 3Y4.01%
Revenue Next 5YN/A
EBIT growth 1Y-50.7%
EBIT growth 3Y-40.7%
EBIT growth 5Y7.65%
EBIT Next Year35.74%
EBIT Next 3Y19.17%
EBIT Next 5YN/A
FCF growth 1Y-42.81%
FCF growth 3Y-36.03%
FCF growth 5Y41.96%
OCF growth 1Y-35.07%
OCF growth 3Y-30.35%
OCF growth 5Y36.13%

BUILDERS FIRSTSOURCE INC / BLDR FAQ

Can you provide the ChartMill fundamental rating for BUILDERS FIRSTSOURCE INC?

ChartMill assigns a fundamental rating of 4 / 10 to BLDR.


What is the valuation status of BUILDERS FIRSTSOURCE INC (BLDR) stock?

ChartMill assigns a valuation rating of 5 / 10 to BUILDERS FIRSTSOURCE INC (BLDR). This can be considered as Fairly Valued.


Can you provide the profitability details for BUILDERS FIRSTSOURCE INC?

BUILDERS FIRSTSOURCE INC (BLDR) has a profitability rating of 5 / 10.


Can you provide the financial health for BLDR stock?

The financial health rating of BUILDERS FIRSTSOURCE INC (BLDR) is 4 / 10.


What is the earnings growth outlook for BUILDERS FIRSTSOURCE INC?

The Earnings per Share (EPS) of BUILDERS FIRSTSOURCE INC (BLDR) is expected to decline by -11.26% in the next year.